Exploring Drugs and Vaccines Associated with Altered Risks and Severity of COVID-19: A UK Biobank Cohort Study of All ATC Level-4 Drug Categories Reveals Repositioning Opportunities. (2021)
Attributed to:
UK Biobank (core renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics13091514
PubMed Identifier: 34575590
Publication URI: http://europepmc.org/abstract/MED/34575590
Type: Journal Article/Review
Volume: 13
Parent Publication: Pharmaceutics
Issue: 9
ISSN: 1999-4923